Literature DB >> 10440558

Causal inference in a clinical trial: a comparative example.

D F Heitjan1.   

Abstract

Recently there has been much interest in methods for analyzing clinical trials of treatments that are subject to noncompliance. In this paper I study a small, simple dataset from a clinical trial of immunosuppressive therapy in the treatment of multiple sclerosis. I apply and compare a range of methods: the as-randomized (intention-to-treat) analysis, the as-treated analysis, estimates based on a nonignorable selection model, and Rubin's causal model. The results differ substantially even in this small dataset that exhibits modest noncompliance. For this reason, data analysts should be clear about which parameters are of greatest importance in the analysis of a clinical trial.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10440558     DOI: 10.1016/s0197-2456(99)00012-4

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  3 in total

1.  Follow up studies in rheumatoid arthritis.

Authors:  R Landewé; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  Bayesian modeling and inference for clinical trials with partial retrieved data following dropout.

Authors:  Qingxia Chen; Ming-Hui Chen; David Ohlssen; Joseph G Ibrahim
Journal:  Stat Med       Date:  2013-04-26       Impact factor: 2.373

3.  Bayesian sequential monitoring design for two-arm randomized clinical trials with noncompliance.

Authors:  Weining Shen; Jing Ning; Ying Yuan
Journal:  Stat Med       Date:  2015-03-10       Impact factor: 2.373

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.